Modeling of multisensory speech perception without causal inference. by John F. Magnotti (3752563)

miR-146a and miR-155 levels decrease at the convalescent stage in patients with <i>V</i>. <i>cholerae</i> O1 infection. by Aziz Bitar (257322)

Preincubation with papaverine leads to decreases in phosphorylation of the myosin light chain in HSV. by Kyle M. Hocking (402156)

Image_5_Decreased Evoked Slow-Activity After tDCS in Disorders of Consciousness.PNG by Armand Mensen (516668)

Reduced proliferation in ciliary regions of <i>Ftm</i>-deficient murine hearts and thickness decrease of <i>Ftm</i>-negative walls. by Christoph Gerhardt (383942)

Aged blood factors decrease cellular responses associated with delayed gingival wound repair by María Paz Saldías (4430032)

“…<div><p>Aging is a gradual biological process characterized by a decrease in cell and organism functions. …”

Rabankyrin-5 Overexpression Increases, whereas Knock-Down Decreases Fluid-Phase Uptake, Specifically by Carsten Schnatwinkel (48)

Kcnk5b requires CaMKK for growth and SHH/<i>shha</i> expression. by Xiaowen Jiang (8291814)

Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011) by Dong-Won Lee (2208223)

“…The prevalences of osteopenia and osteoporosis were 60.8% and 22.0%, respectively, in the sarcopenia group and 45.6% and 13.3% in the non-sarcopenia group (both p < 0.001). After adjusting for multiple variables, the presence of sarcopenia associated with increased the risk of osteopenia, osteoporosis, and a low BMD (OR = 3.227, 95% CI = 2.125–4.899, p < 0.001, OR = 6.952, 95% CI = 3.418–14.139, p < 0.001, and OR = 3.495, 95% CI = 2.315–5.278, p < 0.001, respectively). …”

The decrease of maintenance methyltransferase activity (mMTase) is correlated with the genome hypomethylation occurring during gliomagenesis, and confers poor prognosis in glioma p... by Eric Hervouet (246599)

The balance of HLA-associated fitness increasing and decreasing mutations strongly correlates with set point viral load in newly infected individuals. by Jessica L. Prince (117343)

Panel probit models: Dummy variable which takes a value of 1 for a top 5 publication. by Sergey V. Popov (6719075)

Transient ATX overexpression decreases vessel branching but does not delay retinal vascularization. by Hiroshi Yukiura (741223)

High fat diet decreased tumor latency but did not affect survival in MMTV-PyMT transgenic mice. by Katherine V. Clark-Knowles (368164)

Virucidal activity of LA, SCFA, and succinic acid combinations associated with an optimal vaginal microbiota or BV, representing a non-optimal vaginal microbiota. by Muriel Aldunate (22411177)

EtOH decreased ΔΨm in a subset of esophageal keratinocytes. by Prasanna M. Chandramouleeswaran (3176268)

Significantly decreased levels of CD4⁺CD25⁺ Treg cells in arthropathic Tax transgenic mice. by Takeo Ohsugi (225723)

“…(D) The percentage of CD4⁺CD25⁺Foxp3⁺ Treg cells in CD4⁺ T cells did not differ between arthropathic Tax transgenic mice and non-transgenic mice (n = 6 per group). (E) Arthropathic Tax transgenic mice showed a significant decrease in the percentage of CD4⁺CD25⁺Foxp3⁺ Treg cells in splenic lymphocytes compared with non-transgenic mice (n = 6 per group), ** <i>P</i><0.01.…”

Data from: Spillage and food dust do not decrease efficacy of long-lasting insecticide-incorporated netting against stored product insects by Sabita Ranabhat (17484660)

Blocking of MC1R, MC2R or MC5R causes a decrease in the enucleation ratio of erythrocytes. by Eriko Simamura (720229)

“…The enucleation ratio was decreased in the erythroblasts treated with anti-MC1R nAb, anti-MC2R nAb or anti-MC5R nAb. *, <i>P <</i> 0.0001, each point versus control. n = 3; error bars, s.e.m. …”

Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer by Alexander Henke (145303)

“…Four candidates (Decorin, SPARC, Spry-1, Tsukushi) were immunolocalised in human foetal prostate (weeks 14, 16, 19) and expression of Decorin was evaluated on a human prostate cancer tissue microarray. In embryonic and perinatal rats Decorin, Semaphorin6D, SPARC, Spry-1 and Tsukushi were expressed with varying distribution patterns throughout the mesenchyme at E17.5, E19.5, P0.5 and P6.5. …”